Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CIPRO (TM) DIAGNOSTIC POWDER

K-Number: K872081 · 1987-06-15

ApplicantMiles Pharmaceuticals
Decision Date1987-06-15
Product CodeJTT
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

CIPRO (TM) DIAGNOSTIC POWDER is the device name listed in this FDA 510(k) record. The listed applicant is Miles Pharmaceuticals. It received FDA 510(k) clearance on 1987-06-15 under 510(k) number K872081. The device is classified under product code JTT. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CIPRO (TM) DIAGNOSTIC POWDER?

CIPRO (TM) DIAGNOSTIC POWDER is a medical device that received FDA 510(k) clearance on 1987-06-15. The listed applicant is Miles Pharmaceuticals. The 510(k) number is K872081.

When did CIPRO (TM) DIAGNOSTIC POWDER receive FDA 510(k) clearance?

CIPRO (TM) DIAGNOSTIC POWDER received FDA 510(k) clearance on 1987-06-15, under 510(k) number K872081.

Who is the listed applicant for CIPRO (TM) DIAGNOSTIC POWDER?

The FDA 510(k) record lists Miles Pharmaceuticals as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CIPRO (TM) DIAGNOSTIC POWDER?

The FDA product code for CIPRO (TM) DIAGNOSTIC POWDER is JTT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Miles Pharmaceuticals as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K820578MEZLIN DIAGNOSTIC REAGENT

Related Devices (Code: JTT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K983310SENSITITRE 18-24 HOUR SUSCEPTIBILITY PLATES WITH SPARFLOXACINAccumed Intl., Inc.K935805PASCO MIC AND MIC/ID PANELSPasco Laboratories, Inc.K895362BACTEC PYRAZINAMIDE SUSCEPTIBILITY TESTBd Becton Dickinson Vacutainer Systems PreanalyticK880574MODIFIED IMIPENEM SUSCEPTIBILITY POWDERMerck, Sharp & DohmeK864442NORFLOXACIN SUSCEPTIBILITY POWDERMerck, Sharp & DohmeK860031GEN DIAGNOSTICS' IMIPENEM 10 MCG SUSCEPTIBITY DISKOrganon Teknika Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑